Research at MD Anderson
Scroll Ahead
Research with one goal: end cancer
At MD Anderson, some of the best minds in the world work in partnership with our patients to enable groundbreaking research to better treat and prevent cancer. Here, researchers have the freedom and support to follow a hypothesis and test new theories that can yield breakthroughs that transform the field and the lives of patients. Embedded in the fourth-largest U.S. city — and the most ethnically diverse — our teams work with our neighbors in the Texas Medical Center, the world’s largest medical center, and around the globe to advance our science and to serve our patients. From the first spark of an idea to its translation in our world-leading clinics, we remain invested and determined in our collective focus to end cancer.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer.
A sense of community
Katy Rezvani, M.D., Ph.D.
Professor, Department of Stem Cell Transplantation
Director of Translational Research
There is a sense of community in terms of ‘let’s come together and develop treatments for our patients that could be life-changing.'
Research Highlights
New cancer drug design
2 new AAAS fellows
Better classifying SCLC
Phase I lymphoma trial
Heart disease and risk
New leukemia treatments
Phase II trial results
New CAR T cell therapy
Research by the Numbers
$1.3B
invested in research
188
patents awarded to MD Anderson in FY24
1,556
clinical trials in FY24
MD Anderson's research and training are also aided by more than $172 million in NIH grant funding, which helps power our mission to end cancer.
View our NIH award summaryResearch Areas
Since 1941, MD Anderson has been home to some of the brightest minds across a variety of cancer research areas.
Resources
MD Anderson provides research tools and resources to fuel the discoveries of our scientists.